Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Hemooncology, Taizhou Hospital, Taizhou, China.
Cancer Lett. 2023 Jul 28;567:216285. doi: 10.1016/j.canlet.2023.216285. Epub 2023 Jun 22.
Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxia and hypovascular tumor microenvironment. Nucleolar and spindle associated protein 1 (NUSAP1) is a microtubule-associated protein that is known to be involved in cancer biology. Our study aimed to investigate the role of NUSAP1 in glycolytic metabolism and metastasis in PDAC. Expression and prognostic value of NUSAP1 in PDAC and common gastrointestinal tumors was evaluated. The function of NUSAP1 in PDAC progression was clarified by single-cell RNA-seq and further experiments in vitro, xenograft mouse model, spontaneous PDAC mice model and human tissue microarray. The downstream genes and signaling pathways regulated by NUSAP1 were explored by RNA-Seq. And the regulation of NUSAP1 on Lactate dehydrogenase A (LDHA)-mediated glycolysis and its underlying mechanism was further clarified by CHIP-seq. NUSAP1 was an independent unfavorable predictor of PDAC prognosis that playing a critical role in metastasis of PDAC by regulating LDHA-mediated glycolysis. Mechanically, NUSAP1 could bind to c-Myc and HIF-1α that forming a transcription regulatory complex localized to LDHA promoter region and enhanced its expression. Intriguingly, lactate upregulated NUSAP1 expression by inhibiting NUSAP1 protein degradation through lysine lactylated (Kla) modification, thus forming a NUSAP1-LDHA-glycolysis-lactate feedforward loop. The NUSAP1-LDHA-glycolysis-lactate feedforward loop is one of the underlying mechanisms to explain the metastasis and glycolytic metabolic potential in PDAC, which also provides a novel insights to understand the Warburg effect in cancer. Targeting NUSAP1 would be an attractive paradigm for PDAC treatment.
胰腺导管腺癌 (PDAC) 的特征是缺氧和血管稀少的肿瘤微环境。核仁纺锤体相关蛋白 1 (NUSAP1) 是一种微管相关蛋白,已知其参与癌症生物学。我们的研究旨在研究 NUSAP1 在 PDAC 中的糖酵解代谢和转移中的作用。评估了 NUSAP1 在 PDAC 和常见胃肠道肿瘤中的表达和预后价值。通过单细胞 RNA-seq 以及体外、异种移植小鼠模型、自发性 PDAC 小鼠模型和人类组织微阵列进一步阐明了 NUSAP1 在 PDAC 进展中的作用。通过 RNA-Seq 探索了 NUSAP1 调节的下游基因和信号通路。通过 CHIP-seq 进一步阐明了 NUSAP1 对乳酸脱氢酶 A (LDHA) 介导的糖酵解的调节及其潜在机制。NUSAP1 是 PDAC 预后的独立不利预测因子,通过调节 LDHA 介导的糖酵解在 PDAC 的转移中起关键作用。从机制上讲,NUSAP1 可以与 c-Myc 和 HIF-1α 结合,形成转录调控复合物,定位于 LDHA 启动子区域,增强其表达。有趣的是,乳酸通过抑制赖氨酸乳酸化 (Kla) 修饰的 NUSAP1 蛋白降解来上调 NUSAP1 的表达,从而形成 NUSAP1-LDHA-糖酵解-乳酸正反馈环。NUSAP1-LDHA-糖酵解-乳酸正反馈环是解释 PDAC 转移和糖酵解代谢潜能的潜在机制之一,也为理解癌症中的瓦伯格效应提供了新的见解。靶向 NUSAP1 可能是 PDAC 治疗的一个有吸引力的范例。